Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
Than
More that one iron in the fire.
https://covid-19-diagnostics.jrc.ec.europa.eu/devices/detail/2905
https://www.google.co.uk/maps/place/Ratcliffe+Cottage,+2+Toothill+Rd,+Loughborough+LE11+1PW
How can this be
https://www.google.co.uk/maps/@52.7761875,-1.203497,3a,75y,149.06h,90t/data=!3m7!1e1!3m5!1sfAjjtkxq1WCx3PBM3f742Q!2e0!6shttps:%2F%2Fstreetviewpixels-pa.googleapis.com%2Fv1%2Fthumbnail%3Fpanoid%3DfAjjtkxq1WCx3PBM3f742Q%26cb_client%3Dmaps_sv.tactile.gps%26w%3D203%26h%3D100%26yaw%3D160.06854%26pitch%3D0%26thumbfov%3D100!7i16384!8i8192
https://www.google.co.uk/maps/place/Ratcliffe+Cottage,+2+Toothill+Rd,+Loughborough+LE11+1PW/@52.776047,-1.2056411,17z/data=!3m1!4b1!4m5!3m4!1s0x4879e0ae13677c0f:0xa5b719f001f26c34!8m2!3d52.7760438!4d-1.203447
Big blues last couple of days
Looks like lateral flow tests all round.
Boris stated in parliament today that all their lateral flow test brought and provided by the government come from British companies, he Mentioned a Nottingham company did not catch the name
This could go Ballistic
Thanks, Muck165
Three companies all incorporated at about the same time plus the Christian Stephenson connection, Very interesting stuff.
M19, Saturn Pass, and Agile Life Sciences are all involved in a RTO , Now that would be big
investors currently hold shares in the shell corporation, a reverse merger enables them to realise a profit through the private company’s acquisition of the shell. This is because a reverse merger will mean that the shell corporation becomes active once again.
No expert here, but Medussa19 and Saturn pass are LTD companies as LSAI is a PLC so I guess LSAI shares will rise.
Buy or sell
From what I can see the UK Gov are mainly using Unreliable inefficient natural flow test from China at the moment and surely that has got to change
The article the FT won't let me share was from SEPTEMBER 25 2020
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/2f6c4175-19e6-403e-ac7a-632d5df8fb5f
https://www.ft.com/content/2f6c4175-19e6-403e-ac7a-632d5df8fb5f
But testing experts have raised concerns that these claims are “misleading”, given that it is an antibody test and antibodies only tend to develop several days after infection. For this reason, the World Health Organisation does not recommend the use of antibody-detecting rapid diagnostic tests to find cases of current infection.
or is it Saturn pass
https://alderleyanalytical.com/good-luck-medusa-19/
https://opengovuk.com/company/13014718
Medusa19 have successfully received the CE mark from a European Notified Body for the MeduFlow® test.
MeduFlow® by Medusa19 is the first British designed and manufactured test to obtain a home use CE mark. MeduFlow® is a lateral flow test (LFT) using a simple and comfortable anterior nasal swab to qualitatively detect the SARS-CoV-2 antigen. The product provides results on the spot in 20 minutes.
The MeduFlow® SARS-CoV-2 antigen lateral flow test has been developed using Avacta's proprietary Affimer® platform to identify individuals with a higher viral load of the SARS-CoV-2 virus who are therefore more likely to infect others.
Merry Christmas to all
Nice to end so blue, Good things coming from our cards close to chest team